23 October 2015 - The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended an advanced therapy medicine for marketing authorisation at its October 2015 meeting.

For more details, go to: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/10/news_detail_002416.jsp&mid=WC0b01ac058004d5c1